BEA-17

Waltham, Massachusetts, U.S., September 21, 2026 Mercy BioAnalytics, Inc. has announced that the U.S. Food and Drug Administration (FDA)...

Uppsala, Sweden, September 22, 2026 Beactica Therapeutics AB has announced the initiation of IND-enabling studies for BEA-17, its wholly...